Plaquenil (Hydroxychloroquine Sulfate) – Sanofi
Trusted immune regulation. Backed by decades of clinical use.
Plaquenil by Sanofi is a pharmaceutical-grade antimalarial and immunomodulatory agent widely prescribed for the treatment and long-term management of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE). It is also used in the prevention and treatment of malaria.
By modulating immune signaling, Hydroxychloroquine helps reduce systemic inflammation, joint pain, and organ damage, making it a core medication in rheumatology and autoimmune care.
✅ Key Benefits:
-
Proven effectiveness in RA, lupus, and malaria protocols
-
Helps control inflammation, flare-ups, and immune system overactivity
-
Long half-life supports once-daily dosing for steady relief
-
Well-tolerated oral formulation for ease of use
-
Manufactured by Sanofi — a global leader in pharmaceutical quality
📌 Common Use Cases:
-
Rheumatoid arthritis (RA)
-
Systemic lupus erythematosus (SLE)
-
Malaria prophylaxis and treatment
-
Off-label support in other autoimmune conditions (under physician supervision)
Clinically trusted. Globally prescribed. Reliable relief for chronic inflammation.
⚠️ Use only under the supervision of a licensed healthcare provider. Regular vision monitoring recommended for long-term use.
